Indoleamines in the hypothalamus and area of the midbrain raphe nuclei of male and female rats throughout postnatal development.
We have investigated the changes in the concentrations of serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) in the hypothalamus-preoptic area (HPOA) and midbrain raphe (MR) region of male and female rats throughout development. No sex differences were found in the concentrations of the indoleamines in either of the areas investigated at any stage of development. The 5-HIAA/5-HT molar ratio was maximal at 4 days of age in both the HPOA and MR. A small but significant sex difference in the 5-HIAA/5-HT ratio occurred in the HPOA (higher in males) but not in the MR at 40 days of age, and the ratio was significantly greater in 80-day-old female rats in the HPOA but not MR. Studies using NSD 1015 to block the conversion of 5-hydroxytryptophan to 5-HT showed that a higher rate of 5-HT synthesis occurred in the HPOA of 80-day-old rats compared with the neonatal HPOA and that in 80-day-old rats the rate of 5-HT synthesis was significantly higher in females. These results show that endogenous steroids do not affect the activity of serotoninergic neurons in the HPOA or MR either during or immediately after the critical period of sexual differentiation. In addition, the results from the NSD 1015 experiments show that the high 5-HIAA/5-HT ratio found in neonates does not involve a higher rate of 5-HT synthesis than that in adult rats.
D000818:Animals; D000831:Animals, Newborn / Q000378:metabolism*; D001933:Brain Stem / Q000032:analysis*; D002851:Chromatography, High Pressure Liquid; D004563:Electrochemistry; D005260:Female; D006834:Hydrazines / Q000494:pharmacology; D006897:Hydroxyindoleacetic Acid / Q000032:analysis*; D008297:Male; D008636:Mesencephalon; D011301:Preoptic Area / Q000032:analysis*; D011903:Raphe Nuclei / Q000032:analysis*; D051381:Rats; D011919:Rats, Inbred Strains; D012701:Serotonin / Q000032:analysis*
D006834:Hydrazines; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; C004297:3-hydroxybenzylhydrazine